{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:40:04Z","timestamp":1787661604929,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82301451"],"award-info":[{"award-number":["82301451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02201-4","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T04:21:59Z","timestamp":1734063719000},"page":"2444-2457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Innate Immune Cell Profiling in Peripheral Blood Mononuclear Cells of Patients\u00a0with Moyamoya Disease"],"prefix":"10.1007","volume":"48","author":[{"given":"Chenglong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liujia","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hancheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"issue":"11","key":"2201_CR1","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda, S., and K. Houkin. 2008. Moyamoya disease: Current concepts and future perspectives. Lancet Neurology 7 (11): 1056\u20131066.","journal-title":"Lancet Neurology"},{"issue":"8","key":"2201_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","volume":"21","author":"M Ihara","year":"2022","unstructured":"Ihara, M., Y. Yamamoto, Y. Hattori, W. Liu, H. Kobayashi, H. Ishiyama, et al. 2022. Moyamoya disease: Diagnosis and interventions. Lancet Neurology 21 (8): 747\u2013758.","journal-title":"Lancet Neurology"},{"issue":"2","key":"2201_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5853\/jos.2014.16.2.65","volume":"16","author":"M Fujimura","year":"2014","unstructured":"Fujimura, M., S. Sonobe, Y. Nishijima, K. Niizuma, H. Sakata, S. Kure, et al. 2014. Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene. J Stroke. 16 (2): 65\u201372.","journal-title":"J Stroke."},{"issue":"1","key":"2201_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada, F., Y. Aoki, A. Narisawa, Y. Abe, S. Komatsuzaki, A. Kikuchi, et al. 2011. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. Journal of Human Genetics 56 (1): 34\u201340.","journal-title":"Journal of Human Genetics"},{"issue":"7","key":"2201_CR5","doi-asserted-by":"publisher","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu, W., D. Morito, S. Takashima, Y. Mineharu, H. Kobayashi, T. Hitomi, et al. 2011. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE 6 (7): e22542.","journal-title":"PLoS ONE"},{"issue":"4","key":"2201_CR6","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3171\/2016.2.JNS152173","volume":"126","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q., Y. Liu, D. Zhang, R. Wang, Y. Zhang, S. Wang, et al. 2017. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. Journal of Neurosurgery 126 (4): 1106\u20131113.","journal-title":"Journal of Neurosurgery"},{"issue":"1","key":"2201_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12975-021-00940-2","volume":"13","author":"R Mertens","year":"2022","unstructured":"Mertens, R., M. Graupera, H. Gerhardt, A. Bersano, E. Tournier-Lasserve, M. A. Mensah, et al. 2022. The genetic basis of moyamoya disease. Translational Stroke Research 13 (1): 25\u201345.","journal-title":"Translational Stroke Research"},{"issue":"10","key":"2201_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2176\/nmc.ra.2019-0059","volume":"59","author":"T Mikami","year":"2019","unstructured":"Mikami, T., H. Suzuki, K. Komatsu, and N. Mikuni. 2019. Influence of inflammatory disease on the pathophysiology of moyamoya disease and quasi-moyamoya disease. Neurologia Medico-Chirurgica (Tokyo) 59 (10): 361\u2013370.","journal-title":"Neurologia Medico-Chirurgica (Tokyo)"},{"issue":"1","key":"2201_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13023-022-02238-4","volume":"17","author":"F Jin","year":"2022","unstructured":"Jin, F., and C. Duan. 2022. Identification of immune-infiltrated hub genes as potential biomarkers of Moyamoya disease by bioinformatics analysis. Orphanet Journal of Rare Diseases 17 (1): 80.","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"2201_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.wneu.2017.01.012","volume":"100","author":"JC Mejia-Munne","year":"2017","unstructured":"Mejia-Munne, J. C., J. A. Ellis, N. A. Feldstein, P. M. Meyers, and E. S. Connolly. 2017. Moyamoya and Inflammation. World Neurosurg. 100:575\u2013578.","journal-title":"World Neurosurg."},{"issue":"3","key":"2201_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1227\/neu.0000000000002455","volume":"93","author":"T Chen","year":"2023","unstructured":"Chen, T., W. Wei, J. Yu, S. Xu, J. Zhang, X. Li, et al. 2023. The progression of pathophysiology of moyamoya disease. Neurosurgery 93 (3): 502\u2013509.","journal-title":"Neurosurgery"},{"issue":"4","key":"2201_CR12","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/13813455.2020.1752257","volume":"128","author":"M Mosallaei","year":"2022","unstructured":"Mosallaei, M., N. Ehtesham, S. Rahimirad, M. Saghi, N. Vatandoost, and S. Khosravi. 2022. PBMCs: A new source of diagnostic and prognostic biomarkers. Archives of Physiology and Biochemistry 128 (4): 1081\u20131087.","journal-title":"Archives of Physiology and Biochemistry"},{"issue":"15\u201316","key":"2201_CR13","doi-asserted-by":"publisher","first-page":"e2200026","DOI":"10.1002\/pmic.202200026","volume":"22","author":"M Alexovi\u010d","year":"2022","unstructured":"Alexovi\u010d, M., J. R. Lindner, P. Bober, R. Longuesp\u00e9e, J. Sabo, and K. Davalieva. 2022. Human peripheral blood mononuclear cells: A review of recent proteomic applications. Proteomics 22 (15\u201316): e2200026.","journal-title":"Proteomics"},{"issue":"4","key":"2201_CR14","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1002\/ctm2.1647","volume":"14","author":"P Ge","year":"2024","unstructured":"Ge, P., C. Tao, W. Wang, Q. He, C. Liu, Z. Zheng, et al. 2024. Circulating immune cell landscape and T-cell abnormalities in patients with moyamoya disease. Clinical and Translational Medicine 14 (4): e1647.","journal-title":"Clinical and Translational Medicine"},{"issue":"4","key":"2201_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.immuni.2024.03.007","volume":"57","author":"T Pradeu","year":"2024","unstructured":"Pradeu, T., B. Thomma, S. E. Girardin, and B. Lemaitre. 2024. The conceptual foundations of innate immunity: Taking stock 30 years later. Immunity 57 (4): 613\u2013631.","journal-title":"Immunity"},{"issue":"1","key":"2201_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.chom.2018.12.006","volume":"25","author":"MG Netea","year":"2019","unstructured":"Netea, M. G., A. Schlitzer, K. Placek, L. A. B. Joosten, and J. L. Schultze. 2019. Innate and adaptive immune memory: an evolutionary continuum in the host\u2019s response to pathogens. Cell Host & Microbe 25 (1): 13\u201326.","journal-title":"Cell Host & Microbe"},{"issue":"4","key":"2201_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s12026-024-09464-x","volume":"72","author":"C Liu","year":"2024","unstructured":"Liu, C., P. Ge, B. Zhang, L. Chan, Y. Pang, C. Tao, et al. 2024. Mass cytometry revealed the circulating immune cell landscape across different Suzuki stages of Moyamoya disease. Immunologic Research 72 (4): 654\u2013664.","journal-title":"Immunologic Research"},{"issue":"3","key":"2201_CR18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1021\/acs.chemrev.2c00350","volume":"123","author":"LP Arnett","year":"2023","unstructured":"Arnett, L. P., R. Rana, W. W. Chung, X. Li, M. Abtahi, D. Majonis, et al. 2023. Reagents for mass cytometry. Chemical Reviews 123 (3): 1166\u20131205.","journal-title":"Chemical Reviews"},{"issue":"5","key":"2201_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.cmet.2020.09.013","volume":"32","author":"MN Artyomov","year":"2020","unstructured":"Artyomov, M. N., and J. Van den Bossche. 2020. Immunometabolism in the single-cell era. Cell Metabolism 32 (5): 710\u2013725.","journal-title":"Cell Metabolism"},{"issue":"4","key":"2201_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","volume":"62","author":"M Fujimura","year":"2022","unstructured":"Fujimura, M., T. Tominaga, S. Kuroda, J.C. Takahashi, H. Endo, K. Ogasawara, et al. 2022. 2021 Japanese guidelines for the management of moyamoya disease: guidelines from the research committee on moyamoya disease and japan stroke society. Neurologia Medico-Chirurgica (Tokyo) 62 (4): 165\u2013170.","journal-title":"Neurologia Medico-Chirurgica (Tokyo)"},{"issue":"1","key":"2201_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/STROKEAHA.121.035296","volume":"53","author":"H Sun","year":"2022","unstructured":"Sun, H., W. Li, C. Xia, Y. Ren, L. Ma, A. Xiao, et al. 2022. Angiographic and hemodynamic features in asymptomatic hemispheres of patients with moyamoya disease. Stroke 53 (1): 210\u2013217.","journal-title":"Stroke"},{"issue":"11","key":"2201_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","volume":"28","author":"C Asselman","year":"2022","unstructured":"Asselman, C., D. Hemelsoet, D. Eggermont, B. Dermaut, and F. Impens. 2022. Moyamoya disease emerging as an immune-related angiopathy. Trends in Molecular Medicine 28 (11): 939\u2013950.","journal-title":"Trends in Molecular Medicine"},{"issue":"6","key":"2201_CR23","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1161\/STROKEAHA.124.046999","volume":"55","author":"T Abumiya","year":"2024","unstructured":"Abumiya, T., and M. Fujimura. 2024. Moyamoya vasculopathy and moyamoya-related systemic vasculopathy: a review with histopathological and genetic viewpoints. Stroke 55 (6): 1699\u20131706.","journal-title":"Stroke"},{"issue":"9","key":"2201_CR24","first-page":"599","volume":"93","author":"XM Liu","year":"1980","unstructured":"Liu, X. M., X. Z. Ruan, Z. Cai, B. R. Yu, S. P. He, and Y. H. Gong. 1980. Moyamoya disease caused by leptospiral cerebral arteritis. Chinese Medical Journal (Engl) 93 (9): 599\u2013604.","journal-title":"Chinese Medical Journal (Engl)"},{"issue":"1","key":"2201_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/01.STR.14.1.104","volume":"14","author":"J Suzuki","year":"1983","unstructured":"Suzuki, J., and N. Kodama. 1983. Moyamoya disease\u2013a review. Stroke 14 (1): 104\u2013109.","journal-title":"Stroke"},{"key":"2201_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-093019-123619","volume":"39","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q., and X. Cao. 2021. Epigenetic remodeling in innate immunity and inflammation. Annual Review of Immunology 39:279\u2013311.","journal-title":"Annual Review of Immunology"},{"issue":"1","key":"2201_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","volume":"14","author":"S Liu","year":"2021","unstructured":"Liu, S., V. Galat, Y. Galat, Y. K. A. Lee, D. Wainwright, and J. Wu. 2021. NK cell-based cancer immunotherapy: From basic biology to clinical development. Journal of Hematology & Oncology 14 (1): 7.","journal-title":"Journal of Hematology & Oncology"},{"issue":"8","key":"2201_CR28","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","volume":"25","author":"L Rebuffet","year":"2024","unstructured":"Rebuffet, L., J. E. Melsen, B. Escali\u00e8re, D. Basurto-Lozada, A. Bhandoola, N. K. Bj\u00f6rkstr\u00f6m, et al. 2024. High-dimensional single-cell analysis of human natural killer cell heterogeneity. Nature Immunology 25 (8): 1474\u20131488.","journal-title":"Nature Immunology"},{"issue":"1","key":"2201_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13045-023-01455-z","volume":"16","author":"F Meng","year":"2023","unstructured":"Meng, F., S. Zhang, J. Xie, Y. Zhou, Q. Wu, B. Lu, et al. 2023. Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells. Journal of Hematology & Oncology 16 (1): 62.","journal-title":"Journal of Hematology & Oncology"},{"key":"2201_CR30","doi-asserted-by":"publisher","first-page":"622306","DOI":"10.3389\/fimmu.2021.622306","volume":"12","author":"UC Kucuksezer","year":"2021","unstructured":"Kucuksezer, U. C., E. Aktas Cetin, F. Esen, I. Tahrali, N. Akdeniz, M. Y. Gelmez, et al. 2021. The role of natural killer cells in autoimmune diseases. Frontiers in Immunology 12:622306.","journal-title":"Frontiers in Immunology"},{"issue":"10","key":"2201_CR31","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1161\/STR.0000000000000443","volume":"54","author":"NR Gonzalez","year":"2023","unstructured":"Gonzalez, N. R., S. Amin-Hanjani, O. Y. Bang, C. Coffey, R. Du, J. Fierstra, et al. 2023. Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the american heart association\/american stroke association. Stroke 54 (10): e465\u2013e479.","journal-title":"Stroke"},{"key":"2201_CR32","doi-asserted-by":"publisher","first-page":"759103","DOI":"10.1155\/2013\/759103","volume":"2013","author":"T Chiba","year":"2013","unstructured":"Chiba, T., and K. Umegaki. 2013. Pivotal roles of monocytes\/macrophages in stroke. Mediators of Inflammation 2013:759103.","journal-title":"Mediators of Inflammation"},{"issue":"6","key":"2201_CR33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/bpa.12583","volume":"28","author":"T Zrzavy","year":"2018","unstructured":"Zrzavy, T., J. Machado-Santos, S. Christine, C. Baumgartner, H. L. Weiner, O. Butovsky, et al. 2018. Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts. Brain Pathology 28 (6): 791\u2013805.","journal-title":"Brain Pathology"},{"key":"2201_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2015.08.010","volume":"53","author":"F Mir\u00f3-Mur","year":"2016","unstructured":"Mir\u00f3-Mur, F., I. P\u00e9rez-de-Puig, M. Ferrer-Ferrer, X. Urra, C. Justicia, A. Chamorro, et al. 2016. Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation. Brain, Behavior, and Immunity 53:18\u201333.","journal-title":"Brain, Behavior, and Immunity"},{"issue":"13","key":"2201_CR35","doi-asserted-by":"publisher","first-page":"6712","DOI":"10.3390\/ijms22136712","volume":"22","author":"R Greco","year":"2021","unstructured":"Greco, R., C. Demartini, A.M. Zanaboni, E. Tumelero, A. Persico, E. Candeloro, et al. 2021. CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients. Int J Mol Sci. 22 (13): 6712.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"2201_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.atherosclerosis.2014.02.009","volume":"234","author":"E Shantsila","year":"2014","unstructured":"Shantsila, E., L. D. Tapp, B. J. Wrigley, B. Pamukcu, S. Apostolakis, S. Montoro-Garc\u00eda, et al. 2014. Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis. Atherosclerosis 234 (1): 4\u201310.","journal-title":"Atherosclerosis"},{"issue":"3","key":"2201_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/14737159.2019.1571911","volume":"19","author":"T Matsushita","year":"2019","unstructured":"Matsushita, T., and K. Takehara. 2019. Soluble CD163 is a potential biomarker in systemic sclerosis. Expert Review of Molecular Diagnostics 19 (3): 197\u2013199.","journal-title":"Expert Review of Molecular Diagnostics"},{"issue":"2","key":"2201_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14712\/18059694.2016.105","volume":"52","author":"G Onofre","year":"2009","unstructured":"Onofre, G., M. Kol\u00e1ckov\u00e1, K. Jankovicov\u00e1, and J. Krejsek. 2009. Scavenger receptor CD163 and its biological functions. Acta Medica (Hradec Kralove) 52 (2): 57\u201361.","journal-title":"Acta Medica (Hradec Kralove)"},{"issue":"3","key":"2201_CR39","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1172\/JCI93025","volume":"128","author":"L Guo","year":"2018","unstructured":"Guo, L., H. Akahori, E. Harari, S. L. Smith, R. Polavarapu, V. Karmali, et al. 2018. CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis. The Journal of Clinical Investigation 128 (3): 1106\u20131124.","journal-title":"The Journal of Clinical Investigation"},{"issue":"6\u20138","key":"2201_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.imbio.2006.05.015","volume":"211","author":"MM Polfliet","year":"2006","unstructured":"Polfliet, M. M., B. O. Fabriek, W. P. Dani\u00ebls, C. D. Dijkstra, and T. K. van den Berg. 2006. The rat macrophage scavenger receptor CD163: Expression, regulation and role in inflammatory mediator production. Immunobiology 211 (6\u20138): 419\u2013425.","journal-title":"Immunobiology"},{"issue":"3","key":"2201_CR41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1182\/blood-2003-11-3943","volume":"104","author":"N S\u00e1nchez-S\u00e1nchez","year":"2004","unstructured":"S\u00e1nchez-S\u00e1nchez, N., L. Riol-Blanco, G. de la Rosa, A. Puig-Kr\u00f6ger, J. Garc\u00eda-Bordas, D. Mart\u00edn, et al. 2004. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104 (3): 619\u2013625.","journal-title":"Blood"},{"issue":"3","key":"2201_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.immuni.2017.02.019","volume":"46","author":"T Granot","year":"2017","unstructured":"Granot, T., T. Senda, D. J. Carpenter, N. Matsuoka, J. Weiner, C. L. Gordon, et al. 2017. Dendritic cells display subset and tissue-specific maturation dynamics over human life. Immunity 46 (3): 504\u2013515.","journal-title":"Immunity"},{"issue":"6","key":"2201_CR43","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1084\/jem.20092140","volume":"207","author":"SL Jongbloed","year":"2010","unstructured":"Jongbloed, S. L., A. J. Kassianos, K. J. McDonald, G. J. Clark, X. Ju, C. E. Angel, et al. 2010. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. Journal of Experimental Medicine 207 (6): 1247\u20131260.","journal-title":"Journal of Experimental Medicine"},{"key":"2201_CR44","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3389\/fimmu.2017.00971","volume":"8","author":"IM Leal Rojas","year":"2017","unstructured":"Leal Rojas, I. M., W. H. Mok, F. E. Pearson, Y. Minoda, T. J. Kenna, R. T. Barnard, et al. 2017. Human blood CD1c(+) dendritic cells promote Th1 and Th17 effector function in memory CD4(+) T cells. Frontiers in Immunology 8:971.","journal-title":"Frontiers in Immunology"},{"key":"2201_CR45","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fimmu.2020.00528","volume":"11","author":"JL Rodr\u00edguez-Fern\u00e1ndez","year":"2020","unstructured":"Rodr\u00edguez-Fern\u00e1ndez, J. L., and O. Criado-Garc\u00eda. 2020. The chemokine receptor CCR7 uses distinct signaling modules with biased functionality to regulate dendritic cells. Frontiers in Immunology 11:528.","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"2201_CR46","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","volume":"57","author":"T Kawai","year":"2024","unstructured":"Kawai, T., M. Ikegawa, D. Ori, and S. Akira. 2024. Decoding Toll-like receptors: Recent insights and perspectives in innate immunity. Immunity 57 (4): 649\u2013673.","journal-title":"Immunity"},{"key":"2201_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fimmu.2012.00079","volume":"3","author":"L Oliveira-Nascimento","year":"2012","unstructured":"Oliveira-Nascimento, L., P. Massari, and L. M. Wetzler. 2012. The role of TLR2 in infection and immunity. Frontiers in Immunology 3:79.","journal-title":"Frontiers in Immunology"},{"issue":"5663","key":"2201_CR48","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1093616","volume":"303","author":"SS Diebold","year":"2004","unstructured":"Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 303 (5663): 1529\u201331.","journal-title":"Science."},{"issue":"11","key":"2201_CR49","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai, T., and S. Akira. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends in Molecular Medicine 13 (11): 460\u2013469.","journal-title":"Trends in Molecular Medicine"},{"issue":"4","key":"2201_CR50","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus, A., and S. Ghosh. 2009. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harbor Perspectives in Biology 1 (4): a000034.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"2201_CR51","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2147\/JIR.S140188","volume":"11","author":"S Giridharan","year":"2018","unstructured":"Giridharan, S., and M. Srinivasan. 2018. Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation. Journal of Inflammation Research 11:407\u2013419.","journal-title":"Journal of Inflammation Research"},{"issue":"1","key":"2201_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1600-065X.2012.01095.x","volume":"246","author":"AS Baldwin","year":"2012","unstructured":"Baldwin, A. S. 2012. Regulation of cell death and autophagy by IKK and NF-\u03baB: Critical mechanisms in immune function and cancer. Immunological Reviews 246 (1): 327\u2013345.","journal-title":"Immunological Reviews"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02201-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02201-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02201-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T04:27:15Z","timestamp":1757132835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02201-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2201"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02201-4","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the principles of the Declaration of Helsinki and received approval from the Ethics Committee of Beijing Tiantan Hospital (KY2022\u2013051\u201302).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}